Heart Disease and Erectile Dysfunction

1. Front Matter

   Pages i-x

   PDF

2. Physiology of Erection and Causes of Erectile Dysfunction

   • Aristotelis G. Anastasiadis, Dmitry Droggin, Martin Burchardt, Ridwan Shabsigh

   Pages 1-18

3. Erectile Dysfunction

   • Culley C. Carson

   Pages 19-37

4. Erectile Dysfunction and Cardiovascular Risk Factors

   • Robert A. Kloner

   Pages 39-49

5. Psychologic Aspects of Erectile Dysfunction in Heart Patients

   • Raymond C. Rosen

   Pages 51-64

6. Management of Erectile Dysfunction

   • Harin Padma-Nathan

   Pages 65-88

7. Sildenafil Citrate and the Nitric Oxide/Cyclic Guanosine Monophosphate Signaling Pathway

   • Ian H. Osterloh, Stephen C. Phillips

   Pages 89-116

8. Phosphodiesterase-5 Inhibition

   • Jackie D. Corbin, Stephen R. Rannels, Sharron H. Francis

   Pages 117-130

9. The Hemodynamics of Phosphodiesterase-PDE5 Inhibitors

   • Graham Jackson

   Pages 131-137

10. Cardiovascular Safety of Phosphodiesterase-5 Inhibitors

    • Robert A. Kloner

    Pages 139-161

11. Effect of Phosphodiesterase-5 Inhibition on Coronary Blood Flow in Experimental Animals

    • Ying Jie Chen, Jay H. Traverse, Robert J. Bache

    Pages 163-177

12. Safety and Hemodynamic Effects of Sildenafil in Patients With Coronary Artery Disease

    • Sameer Rohatgi, Howard C. Herrmann

    Pages 179-194

13. Cardiovascular Effects of Nonphosphodiesterase-5 Inhibitor Erectile Dysfunction Therapies

    • Harin Padma-Nathan

    Pages 195-206

14. Potential Cardiac Applications of Phosphodiesterase Type-5 Inhibition

    • Michael Sweeney, Richard L. Siegel

    Pages 207-237

15. The Physiologic Cost of Sexual Activity

    • Robert F. DeBusk

    Pages 239-249

16. Sexual Activity As a Trigger of Myocardial Infarction/Ischemia

    • Robert A. Kloner

    Pages 251-260

17. Sex After Cardiac Events and Procedures

    • Herman A. Taylor Jr.

    Pages 261-270

18. American College of Cardiology/American Heart Association Guidelines on the Use of Sildenafil in Patients With Cardiovascular Disease

    • Adolph M. Hutter Jr

    Pages 271-277

19. Risk of Heart Attack After Sexual Activity

    • Robert F. DeBusk

    Pages 279-288

20. Back Matter

    Pages 289-300

    PDF

Senior physicians, cardiologists, urologists, psychologists, and pharmacologists critically review the relation between heart disease and erectile dysfunction (ED) and explain for the practicing physician the effective new treatment options available for the cardiac patient with ED. The authors detail in concise language the latest thinking about the risk of sexually induced cardiac events, the efficacy and risks to cardiac patients of drugs used to treat sexual dysfunction, and the expert guidelines developed by prominent organizations on the optimal approach to sexual dysfunction in the cardiac patient. They also discuss the physiology of ED and the currently available therapies (sildenafil, tadalafil, and vardenafil) may interact with the cardiac system, and the potential application of newer agents like phosphodiesterase-5 inhibitors to cardiovascular disease.

• cardiovascular
• cardiovascular system
• coronary artery disease
• heart
• hemodynamics
• vascular disease

"This is the first book of its kind. Dr. Cloner and colleagues deserve credit for bringing this important topic to the forefront." - Doody's Health Sciences Book Review Journal

• The Heart Institute, Good Samaritan Hospital, Division of Cardiovascular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, USA

  Robert A. Kloner

Policies and ethics